<DOC>
	<DOCNO>NCT00734916</DOCNO>
	<brief_summary>Immune modulate property parenteral lipid emulsion seem contribute increase risk infection remain associate use total parenteral nutrition . Emulsions base soy bean oil ( SO ) old still widely use lipid source TPN formulation high content omega-6 polyunsaturated fatty acid ( PUFAs ) may drawback . Fish oil-based lipid emulsion ( FO ) , rich omega-3 PUFAs , approve parenteral nutrition many country . Mainly retrospective study clinical outcome septic postoperative patient suggest clinical benefit inclusion FO parenteral nutrition regimen . The exact mechanism behind beneficial immunological effect parenteral FO , however , yet elucidate . Objective : To evaluate effect intravenous infusion FO-based lipid emulsion SO-based emulsion immune function evidence effect peripheral blood leukocyte count function susceptibility oxidative stress . Study design : Randomized placebo control cross-over pilot study healthy volunteer .</brief_summary>
	<brief_title>Immune Modulation Parenteral Lipids</brief_title>
	<detailed_description />
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<criteria>Adult ( &gt; 18 yr age ) Healthy Willingness give write informed consent Smoking &gt; 5 cigarettes/day Diet &gt; 2 portion fatty fish per day Use oral fish oil vitamin substrates History metabolic disorder ( especially diabetes lipid disorder ) History allergic , inflammatory immunological disease History pulmonary , cardiovascular , renal hematological disease Medication use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>total parenteral nutrition</keyword>
	<keyword>infection</keyword>
	<keyword>Infectious complication related parenteral nutrition</keyword>
</DOC>